Evaxion to Present New Preclinical Data for AI-Designed CMV Vaccine Candidate
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.